Sign Up Today and Learn More About PreciseDx Stock
Invest in or calculate the value of your shares in PreciseDx or other pre-IPO companies through EquityZen's platform.
PreciseDx Stock (PRCD)
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.
About PreciseDx Stock
Founded
2019
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
PreciseDx Press Mentions
Stay in the know about the latest news on PreciseDx
Mount Sinai for-profit spin-off raises $21M for diagnostic tech using vast sums of patient data
crainsnewyork • Dec 28, 2024
Study Results from COTA, PreciseDx, and Baptist Health South Florida Confirm Novel AI Test, PreciseBreast is Equivalent to Oncotype DX at Predicting Breast Cancer Recurrence
prnewswire • Dec 09, 2024
PreciseDx's digital pathology AI on par with genomic testing in predicting breast cancer recurrence risks: study
fiercebiotech • Dec 06, 2024
PreciseDx Announces Formation of Scientific Advisory Board
prnewswire • Nov 20, 2024
PreciseDx Secures $20.7 Million Series B
vcnewsdaily • Aug 22, 2024
PreciseDx Management
Leadership team at PreciseDx
Co-Founder and Chief Medical Officer
Michael J. Donovan
Co-Founder and Chairman of the Advisory Board
Carlos Cordon
Join now and verify your accreditation status to gain access to:
- PreciseDx Current Valuation
- PreciseDx Stock Price
- PreciseDx Management
- Available deals in PreciseDx and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- PreciseDx Cap Table and Funding History by Share Class and Liquidity Preferences
- PreciseDx Revenue and Financials
- PreciseDx Highlights
- PreciseDx Business Model
- PreciseDx Risk Factors
- PreciseDx Research Report from SACRA Research
Trading PreciseDx Stock
How to invest in PreciseDx stock?
Accredited investors can buy pre-IPO stock in companies like PreciseDx through EquityZen funds. These investments are made available by existing PreciseDx shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PreciseDx stock?
Shareholders can sell their PreciseDx stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
